The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Anti‐cancer properties of anthraquinones from rhubarb
Abstract
Rhubarb has been used as a traditional Chinese medicine since ancient times and today it is still present in various herbal preparations. In this review the toxicological and anti‐neoplastic potentials of the main anthraquinones from Rhubarb, Rheum palmatum, will be highlighted. It is interesting to note that although the chemical structures of various anthraquinones in this plant are similar, their bioactivities are rather different. The most abundant anthraquinone of rhubarb, emodin, was capable of inhibiting cellular proliferation, induction of apoptosis, and prevention of metastasis. These capabilities are reported to act through tyrosine kinases, phosphoinositol 3‐kinase (PI3K), protein kinase C (PKC), NF‐kappa B (NF‐κB), and mitogen‐activated protein kinase (MAPK) signaling cascades. Aloe‐emodin is another major component in rhubarb found to have anti‐tumor properties. Its anti‐proliferative property has been demonstrated to be through the p53 and its downstream p21 pathway. Our recent proteomic study also suggests that the molecular targets of these two anthraquinones are different. However, both components were found to be able to potentiate the anti‐proliferation of various chemotherapeutic agents. Rhein is the other major rhubarb anthraquinone, although less well studied. This compound could effectively inhibit the uptake of glucose in tumor cells, caused changes in membrane‐associated functions and led to cell death. Interestingly, all three major rhubarb anthraquinones were reported to have in vitro phototoxic. This re‐evaluation of an old remedy suggests that several bioactive anthraquinones of rhubarb possess promising anti‐cancer properties and could have a broad therapeutic potential. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 5, 609–630, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear factor-kappa B and cancer: its role in prevention and therapy
Bharti, A. C., & Aggarwal, B. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01154-1 · Cited by 510
Role of MAP kinase in tumor progression and invasion
Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 509
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
Bech-Otschir, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1630 · Cited by 397
Pecere, T., Gazzola, M. V., Mucignat‐Caretta, C., Parolin, C., Vecchia, F. D., Cavaggioni, A., Basso, G., Diaspro, A., Salvato, B., Carli, M., et al. (2000) · PubMed · Cited by 342
Chen, Y.-C., Yang, L.-L., & Lee, T. J.-F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00255-0 · Cited by 323
Apoptosis-based therapies and drug targets
Fischer, U., & Schulze-Osthoff, K. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401556 · Cited by 282
Molecular mechanism of TNF signaling and beyond
LIU, Z.-G. (2005) · Cell Research · doi:10.1038/sj.cr.7290259 · Cited by 280
Cholesterol and prostate cancer
Freeman, M. R., & Solomon, K. R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10724 · Cited by 266
Oncogenic protein tyrosine kinases: Kit as a human oncogenic tyrosine kinase
Kitamura, Y., & Hirotab, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4273-y · Cited by 260
Su, Y.-T., Chang, H.-L., Shyue, S.-K., & Hsu, S.-L. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.026 · Cited by 255
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hsu, F.-L., Lin, H.-Y., Ko, C.-H., & Tseng, S.-W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01386-2 · Cited by 226
Kuo, P.-L., Lin, T.-C., & Lin, C.-C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01900-8 · Cited by 218
Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome
Uhle, S. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg127 · Cited by 202
Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma
Lee, H.-Z., Hsu, S.-L., Liu, M.-C., & Wu, C.-H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01467-4 · Cited by 198
Emodin Down-Regulates Androgen Receptor and Inhibits Prostate Cancer Cell Growth
Cha, T.-L., Qiu, L., Chen, C.-T., Wen, Y., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3250 · Cited by 178
Review article: anthranoid laxatives and their potential carcinogenic effects
GORKOM, B. A. P. V., VRIES, E. G. E. D., KARRENBELD, & KLEIBEUKER (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00468.x · Cited by 173
Cai, Sun, M., Xing, J., & Corke, H. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0489116 · Cited by 166
Kumar, A., Dhawan, S., & Aggarwal, B. B. (1998) · Oncogene · doi:10.1038/sj.onc.1201998 · Cited by 163
Zhang, L., Chang, C., Bacus, S. S., & Hung, M. (1995) · PubMed · Cited by 162
Toward the rational design of protein kinase casein kinase-2 inhibitors
Sarno, S., Moro, S., Meggio, F., Zagotto, G., Ben, D. D., Ghisellini, P., Battistutta, R., Zanotti, G., & Pinna, L. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00185-7 · Cited by 156
Zhang, L., Lau, Y. K. J., Xia, W., Hortobágyi, G. N., & Hung, M. (1999) · PubMed · Cited by 150
Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells
Shieh, D., Chen, Y.-Y., Yen, M., Chiang, L., & Lin, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.060 · Cited by 150
Yi, J., Yang, J., He, R. L., Gao, F., Sang, H., Tang, X., & Ye, R. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2820-2 · Cited by 149
Battistutta, R., Sarno, S., Moliner, E. D., Papinutto, E., Zanotti, G., & Pinna, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004257200 · Cited by 148
Order or chaos? An evaluation of the regulation of protein kinase CK2
Olsten, M. E. K., & Litchfield, D. W. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-116 · Cited by 141
Oncogenic protein tyrosine kinases
M�nard, S., Casalini, P., Campiglio, M., Pupa, S. M., & Tagliabue, E. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4277-7 · Cited by 137
Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells.
Chen, H.-C., Hsieh, W.-T., Chang, W., & Chung, J.-G. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.03.002 · Cited by 137
Signal transduction pathways: targets for chemoprevention of skin cancer
Bode, A. M., & Dong, Z. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00029-2 · Cited by 130
Huang, Q. B., Shen, H., Shui, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0077 · Cited by 130
Self-citationHuang, Q. B., Shen, H., & Ong, C. N. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.032 · Cited by 129
Self-citationProtein kinase C involvement in aloe‐emodin‐ and emodin‐induced apoptosis in lung carcinoma cell
Lee, H. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704342 · Cited by 125
Mueller, S. O., Schmitt, M. P., Dekant, W., Stopper, H., Schlatter, J. R., Schreier, P. H., & Lutz, W. K. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00027-7 · Cited by 122
Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy
Unger, G. M., Davis, A. R., Slaton, J. W., & Ahmed, K. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481687 · Cited by 120
Lin, J.-G., Chen, G.-W., Li, T., Chouh, S.-T., Tan, T., & Chung, J. (2005) · The Journal of Urology · doi:10.1016/s0022-5347(05)00005-4 · Cited by 118
Immunosuppressive effect of emodin, a free radical generator
Huang, H., Chang, J.-H., Tung, S.-F., Wu, R.-T., Foegh, M. L., & Chu, S. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90393-i · Cited by 117
Kwak, H., Park, M., Park, C., Moon, S., Yoo, D., Lee, H., Lee, S., Kim, M., Lee, H., Shin, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21641 · Cited by 114
Wojcikowski, K., Johnson, D. W., & Gobe, G. C. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.11.011 · Cited by 113
Zhang, L., & Hung, M. (1996) · PubMed · Cited by 113
Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma
Lee, H. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704205 · Cited by 110
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer
Hengstler, J. G., Lange, J., Kett, A., Dornhöfer, N., Meinert, R., Arand, M., Knapstein, P. G., Becker, R., Oesch, F., & Tanner, B. (1999) · PubMed · doi:10.5167/uzh-113865 · Cited by 106
Anti-glioma action of aloe emodin: the role of ERK inhibition
Mijatović, S., Maksimović‐Ivanić, D., Radovic, J., Miljković, D. M., Harhaji-Trajkovic, L. M., Vuckovic, O., Stošić‐Grujičić, S., Stojkovic, M. M., & Trajković, V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4425-8 · Cited by 101
Ravi, R. K., & Bedi, A. (2002) · PubMed · Cited by 100
Carcinogenicity of chrysazin in large intestine and liver of mice.
Mori, H., Sugie, S., Niwa, K., Yoshimi, N., Tanaka, T., & Hirono, I. (1986) · PubMed · Cited by 91
Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin
Jing, X., Ueki, N., Cheng, J., Imanishi, H., & Hada, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01332.x · Cited by 91
Medicinal herbal extracts – renal friend or foe? Part one: The toxicities of medicinal herbs
Wojcikowski, K., Johnson, D. W., & Gobe, G. C. (2004) · Nephrology · doi:10.1111/j.1440-1797.2004.00310.x · Cited by 90
Strategies to target HER2/neu overexpression for cancer therapy
Chen, J., Lan, K., & Hung, M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00040-2 · Cited by 90
In vitro studies on the photobiological properties of aloe emodin and aloin A
Wamer, W. G., Vath, P., & Falvey, D. E. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01242-x · Cited by 89
Characterization of the genotoxicity of anthraquinones in mammalian cells
Mueller, S. O., & Stopper, H. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00064-1 · Cited by 88
Tsujio, I., Tanaka, T., Kudo, T., Nishikawa, T., Shinozaki, K., Grundke, I., Iqbal, K., & Takeda, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01234-5 · Cited by 87
Involvement of p53 in specific anti‐neuroectodermal tumor activity of aloe‐emodin
Pecere, T., Sarinella, F., Salata, C., Gatto, B., Bet, A., Vecchia, F. D., Diaspro, A., Carli, M., Palumbo, M., & Palù, G. (2003) · International Journal of Cancer · doi:10.1002/ijc.11312 · Cited by 84
Martin, G., Bogdanowicz, P., Domagala, F., Ficheux, H., & Pujol, J. ‐. (2003) · Inflammation · doi:10.1023/a:1025040631514 · Cited by 83
Acevedo-Duncan, M. E., Russell, C., Patel, S. K., & Patel, R. S. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.07.012 · Cited by 81
Involvement of Protein Kinase CK2 in Angiogenesis and Retinal Neovascularization
Ljubimov, A. V., Caballero, S., Aoki, A. M., Pinna, L. A., Grant, M. B., & Castellon, R. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0686 · Cited by 79
Wölfle, D., Schmütte, C., Westendorf, J., & Marquardt, H. W. J. (1990) · PubMed · Cited by 78
Effect of Rheum emodi (Revand Hindi) on renal functions in rats
Alam, M. M. A., Javed, K., & Jafri, M. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.08.028 · Cited by 75
Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougère, M., Henry, E., Galteau, M. M., Dicato, M. A., & Diederich, M. F. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.032 · Cited by 74
Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb.
Shi, Y., Fukai, T., Sakagami, H., Kuroda, J., Miyaoka, R., Tamura, M., Yoshida, N., & Nomura, T. (2001) · PubMed · Cited by 73
Yang, J., Li, H., Chen, Y., Wang, X., Shi, G., Hu, Q.-S., Kang, X., Lü, Y., Tang, X., Guo, Q.-S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.016 · Cited by 70
Mendes, A. F., Caramona, M. M., Carvalho, A. P., & Lopes, M. C. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910104.x · Cited by 68
Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin
Mijatović, S., Maksimović‐Ivanić, D., Radovic, J., Miljković, D. M., Kaluđerović, G. N., Sabo, T. J., & Trajković, V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5041-3 · Cited by 68
Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Kim, M. S., Park, M. J., Kim, S. J., Lee, C. H., Yoo, H., Shin, S. H., Song, E. S., & Lee, S. H. (2005) · PubMed · Cited by 67
Genotoxicity of aloeemodin in vitro and in vivo
Heidemann, A., Völkner, W., & Mengs, U. (1996) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(95)00084-4 · Cited by 66
The hepatotoxicity of rhein involves impairment of mitochondrial functions
Bironaitė, D., & Öllinger, K. M. (1997) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(96)03747-7 · Cited by 66
LEE, H., LIN, C., Yang, W., LEUNG, W., & Chang, S. C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.036 · Cited by 62
Effects of rhein on human articular chondrocytes in alginate beads
Sanchez, C., Mathy-Hartert, M., Deberg, M. A., Ficheux, H., Reginster, J. L., & Henrotin, Y. E. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01485-5 · Cited by 61
Signaling pathway for aloe‐emodin‐induced apoptosis in human H460 lung nonsmall carcinoma cell
Yeh, F., Wu, C., & Lee, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11185 · Cited by 59
Füllbeck, M., Huang, X., Dumdey, R., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-97 · Cited by 56
Photochemistry and Phototoxicity of Aloe Emodin¶
Vath, P., Wamer, W. G., & Falvey, D. E. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0750346papoae2.0.co2 · Cited by 55
Mahabeleshwar, G. H., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308941200 · Cited by 53
Mijatović, S., Maksimović‐Ivanić, D., Radovic, J., Popadic, D. M., Momčilović, M. B., Harhaji-Trajkovic, L. M., Miljković, D. M., & Trajković, V. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4089-9 · Cited by 47
Oncogene signal transduction inhibitors from medicinal plants.
Chang, C., Ashendel, C. L., Geahlen, R. L., McLaughlin, J. L., & Waters, D. J. (1996) · PubMed · Cited by 42
Rakheja, D., Kapur, P., Hoang, M. P., Roy, L., & Bennett, M. J. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.05.045 · Cited by 35
Lee, H., Wu, C., & Chang, S.-P. (2004) · International Journal of Cancer · doi:10.1002/ijc.20676 · Cited by 34
Strickland, F. M., Muller, H., Stephens, L. C., BUCANA, C. D., Donawho, C. K., Sun, Y. K., & Pelley, R. P. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720407iopcmi2.0.co2 · Cited by 33
Anthraquinone cytotoxicity and apoptosis in primary cultures of rat hepatocytes
Kågedal, K., Bironaitė, D., & Öllinger, K. M. (1999) · Free Radical Research · doi:10.1080/10715769900300981 · Cited by 31
Mueller, S. O., Lutz, W. K., & Stopper, H. (1998) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(98)00047-3 · Cited by 31
Photosensitization of human leukemic cells by anthracenedione antitumor agents.
Hartley, J. A., Forrow, S., Souhami, R. L., Reszka, K., & Lown, J. W. (1990) · PubMed · Cited by 27
Developmental toxicity evaluation of emodin in rats and mice
Jahnke, G. D., Price, C. J., Marr, M. C., Myers, C. B., & George, J. D. (2004) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20002 · Cited by 26
Xiao Jing, W. A. N. G., Yang, J., Hui, C. A. N. G., Zou, Y., & Yi, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290321 · Cited by 18
Tanaka, T., Tsujio, I., Nishikawa, T., Shinosaki, K., Kudo, T., & Takeda, M. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00004 · Cited by 16
Badgwell, D. B., Walker, C. M., Baker, W. T., & Strickland, F. M. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.10170 · Cited by 16
Jing, Y., Yi, J., Chen, Y., Hu, Q.-S., Shi, G., Li, H., & Tang, X. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.3.235 · Cited by 14
Cited by
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
Dong, X., Zeng, Y., Liu, Y., You, L., Yin, X., Fu, J., & Ni, J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6532 · Cited by 591
Chemistry and Biology of Mycotoxins and Related Fungal Metabolites
Bräse, S., Encinas, A., Keck, J., & Nising, C. F. (2009) · Chemical Reviews · doi:10.1021/cr050001f · Cited by 587
Anthraquinones As Pharmacological Tools and Drugs
Malik, E. M., & Müller, C. E. (2016) · Medicinal Research Reviews · doi:10.1002/med.21391 · Cited by 448
The retinoid X receptors and their ligands
Dawson, M. I., & Xia, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.014 · Cited by 387
Targeting apoptosis pathways in cancer by Chinese medicine
Li-Weber, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.07.015 · Cited by 318
Metadata
- Authors
- Huang, Q., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2006-10-04
- Volume
- 27
- Issue
- 5
- Pages
- 609-630
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2124572106
- Cited by
- 559
- References
- 82
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.